CLASS II Drug recall · Reported 4 May 2022 · FDA Enforcement Report
NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder recalled
Olympia Compounding Pharmacy is recalling NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitution, Multi-Dose, distributed nationwide in the US. The recall was initiated on 4 Apr 2022 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0828-2022
- FDA event ID
- 89938
- Recalling firm
- Olympia Compounding Pharmacy, Orlando, FL
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 4 Apr 2022
- FDA classified
- 27 Apr 2022
- Reported
- 4 May 2022
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
- Drug class
- Injectable & IV Drugs
Timeline
| 4 Apr 2022 | Recall initiated by company | |
| 27 Apr 2022 | Classified by FDA | +23 days |
| 4 May 2022 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Failed Reconstitution time
Product as listed by the FDA
NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitution, Multi-Dose 500 mg Per Vial, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0083-00
Where it was distributed
Distributed Nationwide in the USA
Questions about this recall
Why was it recalled?
Failed Reconstitution time
Which lots are affected?
Lot: F41116 BUD: 6/16/2022,
Where was it sold?
Distributed Nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
33 other products · FDA event 89938This product is part of a recall event; the main page for the event is NB-243, Papaverine 30mg/ml . Phentolamine 3mg/ml . recalled.
More recalls from Olympia Compounding Pharmacy
All 94| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Sermorelin Acetate Lyophilized powder recalled | Olympia Compounding Pharmacy | Sterility | Nationwide |
| Drug | CLASS II | Lipo-Mino-Mix Pyridoxine HCL recalled by Olympia Compounding Pharmacy | Olympia Compounding Pharmacy | Sterility | Nationwide |
| Drug | CLASS II | Zinc Chloride (0.5 mg/mL), Multi-Dose vial recalled | Olympia Compounding Pharmacy | Sterility | Nationwide |
| Drug | CLASS II | NAD+ Nicotinamide Adenine Dinucleotide recalled | Olympia Compounding Pharmacy | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate 200 mg/mL in Sesame Oil recalled | Olympia Compounding Pharmacy | Sterility | Nationwide |